Inactive Instrument

News Active Biotech AB Other OTC

Equities

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Active Biotech provides update on the clinical phase Ib/IIa study with tasquinimod in relapsed refractory multiple myeloma	15/07	AQ
Active Biotech Provides Update on the Clinical Phase Ib/IIa Study with Tasquinimod in Relapsed Refractory Multiple Myeloma	15/07	CI
Active Biotech enters agreement for a clinical study of tasquinimod in myelofibrosis	01/07	AQ
Active Biotech Enters Agreement for A Clinical Study of Tasquinimod in Myelofibrosis	01/07	CI
Number of shares and votes in Active Biotech	31/05	AQ
Clinical activity and safety of naptumomab and docetaxel to be presented at ASCO 2024	28/05	AQ
Annual General Meeting of Active Biotech AB	22/05	AQ
Active Biotech Secures Exclusive Licensing Rights to Multiple Myeloma Drug	22/05	MT
Active Biotech acquires exclusive rights to patents of tasquinimod in combination therapy	22/05	AQ
Active Biotech Enters into an Exclusive License Agreement with the Wistar Institute of Anatomy and Biology	22/05	CI
Active Biotech : Interview with Prof. Dr. Axel Glasmacher, Independent Board Member at Active Biotech	13/05	PU
Active Biotech Q1 2024 - Approching Naptumomab Topline Data in Lung Cancer	13/05	AQ
Active Biotech Interim Report Q1 2024	08/05	AQ
Active Biotech AB Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05	CI
Annual Report 2023 Active Biotech AB (publ)	22/04	AQ
Active Biotech announces start of enrollment to the clinical phase I biodistribution study with laquinimod eye drops	03/04	AQ
Active Biotech AB Announces Start of Enrollment to the Clinical Phase I Biodistribution Study with Laquinimod Eye Drops	03/04	CI
Active Biotech Q4 2023 - Three Externally Funded Trials in 2024	09/02	AQ
Active Biotech Year End Report 2023	08/02	AQ
Active Biotech AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	08/02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Active Biotech AB Other OTC

Equities

Summary

Filters